Cargando…
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
New therapeutic targets are a valuable resource in the struggle to reduce the morbidity and mortality associated with the COVID-19 pandemic, caused by the SARS-CoV-2 virus. Genome-wide association studies (GWAS) have identified risk loci, but some loci are associated with co-morbidities and are not...
Autores principales: | Moll, Tobias, Odon, Valerie, Harvey, Calum, Collins, Mark O, Peden, Andrew, Franklin, John, Graves, Emily, Marshall, Jack N.G., Souza, Cleide dos Santos, Zhang, Sai, Azzouz, Mimoun, Gordon, David, Krogan, Nevan, Ferraiuolo, Laura, Snyder, Michael P, Shaw, Pamela J, Rehwinkel, Jan, Cooper-Knock, Johnathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923113/ https://www.ncbi.nlm.nih.gov/pubmed/35291294 http://dx.doi.org/10.1101/2022.03.06.483172 |
Ejemplares similares
-
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
por: Moll, Tobias, et al.
Publicado: (2022) -
Integrated Bioinformatic Investigation of EXOSCs in Hepatocellular Carcinoma Followed by the Preliminary Validation of EXOSC5 in Cell Proliferation
por: Zhang, Yujing, et al.
Publicado: (2022) -
Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes
por: Julian, Thomas H, et al.
Publicado: (2021) -
Advances in the Genetic Classification of ALS
por: Cooper-Knock, Johnathan, et al.
Publicado: (2021) -
Disrupted glycosylation of lipids and proteins is a cause of neurodegeneration
por: Moll, Tobias, et al.
Publicado: (2020)